{"id":393603,"date":"2025-02-11T00:01:00","date_gmt":"2025-02-10T23:01:00","guid":{"rendered":"https:\/\/medizinonline.com\/sglt-2-i-consider-for-all-ckd-patients\/"},"modified":"2025-02-10T21:40:23","modified_gmt":"2025-02-10T20:40:23","slug":"sglt-2-i-consider-for-all-ckd-patients","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/sglt-2-i-consider-for-all-ckd-patients\/","title":{"rendered":"SGLT-2-i: consider for all CKD patients"},"content":{"rendered":"\n<p><strong>Targeted early detection measures and timely treatment of chronic<em> kidney disease<\/em> (CKD) are extremely important to halt progression and manage complications. The determination of albuminuria makes it possible to make the diagnosis earlier than by looking at the eGFR alone. The SGLT-2 inhibitors originally developed for the treatment of diabetes are not only cardioprotective, but also counteract the progression of renal function loss.    <\/strong><\/p>\n\n\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fsglt-2-i-consider-for-all-ckd-patients%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Targeted early detection measures and timely treatment of chronic kidney disease (CKD) are extremely important to halt progression and manage complications. The determination of albuminuria makes it possible to make&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/en\/my-account\/packages\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/en\/log-in\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fen%2Fsglt-2-i-consider-for-all-ckd-patients%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":393606,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Chronic kidney disease  ","footnotes":""},"category":[11548,11359,11513,11297,11413],"tags":[12828,12831,12821,17741,18549],"powerkit_post_featured":[],"class_list":["post-393603","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-cardiology","category-congress-reports","category-general-internal-medicine","category-nephrology","tag-albuminuria","tag-chronic-kidney-disease","tag-ckd-en","tag-egfr-en","tag-sglt-2-i-en","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-19 07:36:28","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":393595,"slug":"sglt-2-i-a-envisager-pour-tous-les-patients-atteints-dirc","post_title":"SGLT-2-i : \u00e0 envisager pour tous les patients atteints d'IRC","href":"https:\/\/medizinonline.com\/fr\/sglt-2-i-a-envisager-pour-tous-les-patients-atteints-dirc\/"},"it_IT":{"locale":"it_IT","id":393673,"slug":"sglt-2-i-considerare-per-tutti-i-pazienti-con-ckd","post_title":"SGLT-2-i: considerare per tutti i pazienti con CKD","href":"https:\/\/medizinonline.com\/it\/sglt-2-i-considerare-per-tutti-i-pazienti-con-ckd\/"},"pt_PT":{"locale":"pt_PT","id":393668,"slug":"sglt-2-i-considere-para-todos-os-doentes-com-drc","post_title":"SGLT-2-i: considere para todos os doentes com DRC","href":"https:\/\/medizinonline.com\/pt-pt\/sglt-2-i-considere-para-todos-os-doentes-com-drc\/"},"es_ES":{"locale":"es_ES","id":393587,"slug":"sglt-2-i-considerar-para-todos-los-pacientes-con-erc","post_title":"SGLT-2-i: considerar para todos los pacientes con ERC","href":"https:\/\/medizinonline.com\/es\/sglt-2-i-considerar-para-todos-los-pacientes-con-erc\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/393603","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=393603"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/393603\/revisions"}],"predecessor-version":[{"id":394623,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/393603\/revisions\/394623"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/393606"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=393603"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=393603"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=393603"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=393603"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}